| P50 | author | Pierre Sokoloff | Q88032459 |
| | Jorge Diaz | Q44051683 |
| P2093 | author name string | Jacques Louvel | |
| | René Pumain | |
| | Ludovic Leriche | |
| P2860 | cites work | Study of a new schizophrenomimetic drug; sernyl. | Q52771570 |
| | A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia. | Q53436797 |
| | Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. | Q55066633 |
| | Basal forebrain in the context of schizophrenia | Q56883821 |
| | D1 and D2 Receptor Gene Expression in the Rat Frontal Cortex: Cellular Localization in Different Classes of Efferent Neurons | Q59578537 |
| | Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex | Q71105549 |
| | Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides | Q71962723 |
| | Clozapine promotes approach-oriented behavior in male mice | Q72808215 |
| | Phencyclidine-induced alterations of rat electrophysiology | Q72905601 |
| | Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum | Q73083238 |
| | Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals | Q73199976 |
| | Dopamine D3 receptors expressed by all mesencephalic dopamine neurons | Q73258546 |
| | Ultrastructural Double-Labelling Study of Dopamine Terminals and GABA-Containing Neurons in Rat Anteromedial Cerebral Cortex | Q74428796 |
| | Actions at sites other than D(3) receptors mediate the effects of BP897 on l-DOPA-induced hyperactivity in monoamine-depleted rats | Q79824323 |
| | The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence | Q81860473 |
| | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
| | Synaptic organisation of the basal ganglia | Q24544917 |
| | Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin | Q24564132 |
| | F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile | Q24564964 |
| | Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist | Q28141108 |
| | Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial | Q28244389 |
| | Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 |
| | Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain | Q28294618 |
| | Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor | Q28327633 |
| | A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons | Q28368794 |
| | A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice | Q28506099 |
| | Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 |
| | Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents | Q28564581 |
| | Overlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate N-methyl-D-aspartate receptors in rat nucleus accumbens | Q28576445 |
| | Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors | Q28589624 |
| | Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice | Q28593197 |
| | Recent advances in the phencyclidine model of schizophrenia | Q29618917 |
| | Is the acute NMDA receptor hypofunction a valid model of schizophrenia? | Q30459655 |
| | Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine | Q30494233 |
| | Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens | Q30499463 |
| | Do we still believe in the dopamine hypothesis? New data bring new evidence | Q30906669 |
| | The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia | Q33537860 |
| | Volume transmission in the CNS and its relevance for neuropsychopharmacology. | Q33633064 |
| | Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia | Q34090017 |
| | Spillover and synaptic cross talk mediated by glutamate and GABA in the mammalian brain. | Q34093945 |
| | Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment | Q34171445 |
| | BP-897 Bioprojet | Q34182457 |
| | Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction | Q34317550 |
| | The emerging role of glutamate in the pathophysiology and treatment of schizophrenia | Q34353738 |
| | Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats | Q34379746 |
| | Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective | Q34546324 |
| | A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. | Q34568745 |
| | Dopamine in schizophrenia: a review and reconceptualization | Q34568816 |
| | Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex | Q44238745 |
| | Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex | Q44362504 |
| | Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function | Q44436562 |
| | In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. | Q45986502 |
| | Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists | Q46365816 |
| | Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort | Q47997393 |
| | Modulation of cocaine self-administration in the rat through D-3 dopamine receptors | Q48266278 |
| | Dopamine D3 receptor mRNA and binding sites in human brain | Q48316464 |
| | Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice. | Q48323251 |
| | Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures | Q48346124 |
| | Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil | Q48352448 |
| | PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs | Q48386191 |
| | Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo | Q48429468 |
| | Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice | Q48443202 |
| | Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. | Q48623758 |
| | Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: A topographical study | Q48641484 |
| | Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice | Q48745660 |
| | Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study | Q48787746 |
| | Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. | Q48848853 |
| | Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO. | Q49154108 |
| | The synaptic organization of the caudate nucleus. | Q51120868 |
| | Characteristics of excitatory and inhibitory synapses in the central nervous system of the cat. | Q51248989 |
| | The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. | Q51861343 |
| | From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment | Q34632695 |
| | Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders | Q35143623 |
| | A dopaminergic deficit hypothesis of schizophrenia: the path to discovery | Q35236663 |
| | On the significance of subterritories in the "accumbens" part of the rat ventral striatum | Q35536722 |
| | Half a century of antipsychotics and still a central role for dopamine D2 receptors | Q35595235 |
| | Glutamate as a therapeutic target in psychiatric disorders | Q35847653 |
| | The principal features and mechanisms of dopamine modulation in the prefrontal cortex | Q35894171 |
| | Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | Q36085612 |
| | The dopamine D3 receptor and drug dependence: effects on reward or beyond? | Q36166618 |
| | The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders | Q36448714 |
| | Mesocortical dopamine modulation of executive functions: beyond working memory | Q36467150 |
| | The structural evolution of dopamine D3 receptor ligands: structure-activity relationships and selected neuropharmacological aspects | Q36564340 |
| | Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors | Q36670129 |
| | Dopamine D3 receptor ligands for the treatment of tobacco dependence | Q36677397 |
| | The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. | Q36724640 |
| | Selective dopamine D3 receptor antagonists: a review 2001-2005. | Q37067409 |
| | The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions | Q37425054 |
| | Glutamatergic transmission in schizophrenia: from basic research to clinical practice | Q37980657 |
| | The current status of the dopamine hypothesis of schizophrenia | Q39577491 |
| | Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo | Q39668353 |
| | The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study | Q40029733 |
| | Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. | Q40496424 |
| | Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors | Q41211972 |
| | Dopamine D2 and D3 receptors inhibit dopamine release | Q41449697 |
| | The D3 dopamine receptor: neurobiology and potential clinical relevance. | Q41602038 |
| | Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. | Q41675749 |
| | Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII | Q41851301 |
| | In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO. | Q41909369 |
| | The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade | Q42167008 |
| | A functional test identifies dopamine agonists selective for D3 versus D2 receptors. | Q42279296 |
| | Complementary distribution of vesicular glutamate transporters 1 and 2 in the nucleus accumbens of rat: Relationship to calretinin-containing extrinsic innervation and calbindin-immunoreactive neurons | Q42446308 |
| | Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: co-localization at synapses with the GluR2/3 subunit of the AMPA receptor | Q42466056 |
| | Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. | Q42528675 |
| | Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat. | Q42546308 |
| | The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO. | Q42623258 |
| | Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics | Q42949861 |
| | The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. | Q42955835 |
| | Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925. | Q43277003 |
| | Recovery of neuropsychological functions during reduction in use of phencyclidine | Q43970800 |
| | Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism | Q44026650 |
| P433 | issue | 2 | |
| P921 | main subject | schizophrenia | Q41112 |
| | dopamine | Q170304 |
| P304 | page(s) | 107-124 | |
| P577 | publication date | 2012-09-22 | |
| P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
| P1476 | title | Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia | |
| P478 | volume | 386 | |